Related Experiment Video
Updated: Apr 23, 2026
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Validation of EORTC IN-PATSAT32 for Chinese patients with gastrointestinal cancer
Jishui Zhang1, Shumin Xie2, Jiahao Liu2
1The Second Department of General Surgery, Cangzhou Central Hospital, Hebei, People's Republic of China.
Purpose:
To test the psychometric properties and applicability of the European Organization for Research and Treatment of Cancer In-patient Satisfaction with Care Questionnaire 32 (EORTC IN-PATSAT32) for Chinese patients with gastrointestinal cancer.
Patients And Methods:
A total of 106 inpatients with gastrointestinal cancer at Cangzhou Center Hospital were enrolled in this study. All were treated at Cangzhou Center Hospital from July 2013-March 2014. All participants self-administered the EORTC IN-PATSAT32 and EORTC Quality of Life Questionnaire - Core 30 (EORTC QLQ-C30).
Results:
The Cronbach's α coefficients were >0.70 for all scales of the EORTC IN-PATSAT32. Multitrait scaling analysis showed that all-item scale correlation coefficients met the standard of convergent validity, while only 50.0% met the standard of discriminant validity. A weak correlation was found between the scales and single items of the EORTC IN-PATSAT32 and EORTC QLQ-C30.
Conclusion:
The EORTC IN-PATSAT32 appears to be a reliable, valid, and acceptable instrument for measuring patient satisfaction among Chinese patients with gastrointestinal cancer.
